KURA vs REGN: Which Stock is Better?
Side-by-side comparison of Kura Oncology Inc and Regeneron Pharmaceuticals Inc in 2026
KURA
Kura Oncology Inc
—
REGN
Regeneron Pharmaceuticals Inc
$678.94
Key Metrics Comparison
| Metric | KURA | REGN | Winner |
|---|---|---|---|
| Market Cap | $861.12M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze KURA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KURA or REGN a better investment?
Comparing KURA and REGN: Kura Oncology Inc has a market cap of $861.12M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KURA and REGN?
KURA (Kura Oncology Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KURA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KURA or REGN?
Both KURA and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: KURA or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: KURA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $861.12M for KURA.
Should I buy KURA or REGN in 2026?
Both KURA and REGN have investment merit. KURA trades at $N/A while REGN trades at $678.94. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KURA and REGN stock?
Key differences: Market Cap ($861.12M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy KURA or REGN in 2026?
The choice between KURA and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KURA and REGN?
KURA (Kura Oncology Inc) has a market cap of $861.12M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.